Otonomy to Present at Raymond James 2020 Human Health Innovation Conference

Rhea-AI Summary

Otonomy, a biopharmaceutical company, announced that its CEO, David A. Weber, Ph.D., will present a company overview at the Raymond James 2020 Human Health Innovation Conference on June 18, 2020, at 2:20 p.m. ET. The presentation will be available via a live audio webcast on Otonomy’s website. The company focuses on developing innovative therapeutics for neurotology, leveraging drug delivery technology to address conditions like Ménière’s disease, hearing loss, and tinnitus.

SAN DIEGO, June 11, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D., president and chief executive officer, is scheduled to present a company overview at the Raymond James 2020 Human Health Innovation Conference (Virtual) on Thursday June 18, 2020 at 2:20 p.m. ET (11:20 a.m. PT).

A live audio webcast of the presentations will be available through the Events page of the company's website (www.otonomy.com). 

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media Inquiries:
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries:
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com

FAQ

When will Otonomy present at the Raymond James 2020 Human Health Innovation Conference?

Otonomy's presentation is scheduled for June 18, 2020, at 2:20 p.m. ET.

Who is presenting for Otonomy at the conference?

David A. Weber, Ph.D., CEO of Otonomy, will present at the conference.

How can I access the Otonomy presentation from the conference?

The presentation will be available via a live audio webcast on Otonomy’s website.

What does Otonomy focus on in its research and development?

Otonomy is dedicated to developing therapeutics for neurotology, including treatments for Ménière’s disease, hearing loss, and tinnitus.

What innovative technology does Otonomy utilize?

Otonomy uses drug delivery technology to achieve sustained drug exposure for ear-related conditions.